INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.88 Cr | ₹-0.85 Cr | ₹0.91 Cr | ₹0.14 Cr | ₹-0.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDO US BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹5.88 Cr |
| Mar2025 | ₹-0.85 Cr |
| Mar2024 | ₹0.91 Cr |
| Mar2023 | ₹0.14 Cr |
| Mar2022 | ₹-0.08 Cr |
How is Net Cash Inflow / Outflow of INDO US BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.88 Cr | Positive | |
| Mar2025 | ₹-0.85 Cr | Negative | |
| Mar2024 | ₹0.91 Cr | 544.68 | |
| Mar2023 | ₹0.14 Cr | Positive | |
| Mar2022 | ₹-0.08 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹137.7 Cr | 3.3% | -6.2% | -50.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,564.7 Cr | 3.6% | 2% | -33.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,252.0 Cr | 2.7% | -0.7% | 3.6% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,527.1 Cr | 3.5% | 17.4% | 35.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹949.0 Cr | 8.1% | 15.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹574.4 Cr | 1.6% | 10.4% | 29.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 3.3% |
-6.2% |
-50.4% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses